REC: CardioClinics最新文献

英文中文

Atención primaria: superpoderes en prevención

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.08.002

Raquel Campuzano Ruiz , Vicente Arrarte Esteban

引用次数: 0

IV informe de actividad y recursos de la Asociación de Imagen Cardiaca de la Sociedad Española de Cardiología (2022)

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.10.010

Jaume Agüero Ramón-Llin , Amparo Martínez-Monzonís , Covadonga Fernández-Golfín , Marta Alamar Cervera , Manuel Barreiro-Pérez

Introduction and objectives

The 2022 Registry of the Cardiovascular Imaging Association of the Spanish Society of Cardiology is presented.

Methods

67 Spanish hospitals were invited to participate in the registry. Participation was voluntary and data collection was carried out through an online questionnaire. The questionnaire focused on data on resource endowment and activity.

Results

53 hospitals participated, most of them public (88.9%) and of typologies 3 or 4. The average number of cardiologists with preferential dedication to cardiac imaging was 4.2. A 38.9% of centers have imaging technicians. The availability of ultrasound machines and age indicates a trend towards better equipment and renewal. In 25.9% of centers, cardiologists only perform echocardiography, and 74.1% participate in at least one other modality (computed tomography [CT], magnetic resonance imaging, or nuclear medicine). The average annual activity was: 9590 echocardiograms, 516 magnetic resonance imaging, 631 CT scans and 607 nuclear medicine studies, with marked inter-center variability despite stratifying by hospital type. An increase in stress echo, transthoracic echocardiography in intervention and CT is observed. In 90% of centers, echocardiograms are performed by other specialties, especially in the form of echocardioscopy by the ICU and emergency services, and to a lesser extent internal medicine, anesthesiology and neurology.

Conclusions

The Spanish Cardiac Imaging Registry of 2022 allows us to know the current situation and temporal trend in terms of resources and activity, the differences between centers and identify potential areas of improvement for the future.

{"title":"IV informe de actividad y recursos de la Asociación de Imagen Cardiaca de la Sociedad Española de Cardiología (2022)","authors":"Jaume Agüero Ramón-Llin , Amparo Martínez-Monzonís , Covadonga Fernández-Golfín , Marta Alamar Cervera , Manuel Barreiro-Pérez","doi":"10.1016/j.rccl.2024.10.010","DOIUrl":"10.1016/j.rccl.2024.10.010","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The 2022 Registry of the Cardiovascular Imaging Association of the Spanish Society of Cardiology is presented.</div></div><div><h3>Methods</h3><div>67 Spanish hospitals were invited to participate in the registry. Participation was voluntary and data collection was carried out through an online questionnaire. The questionnaire focused on data on resource endowment and activity.</div></div><div><h3>Results</h3><div>53 hospitals participated, most of them public (88.9%) and of typologies 3 or 4. The average number of cardiologists with preferential dedication to cardiac imaging was 4.2. A 38.9% of centers have imaging technicians. The availability of ultrasound machines and age indicates a trend towards better equipment and renewal. In 25.9% of centers, cardiologists only perform echocardiography, and 74.1% participate in at least one other modality (computed tomography [CT], magnetic resonance imaging, or nuclear medicine). The average annual activity was: 9590 echocardiograms, 516 magnetic resonance imaging, 631 CT scans and 607 nuclear medicine studies, with marked inter-center variability despite stratifying by hospital type. An increase in stress echo, transthoracic echocardiography in intervention and CT is observed. In 90% of centers, echocardiograms are performed by other specialties, especially in the form of echocardioscopy by the ICU and emergency services, and to a lesser extent internal medicine, anesthesiology and neurology.</div></div><div><h3>Conclusions</h3><div>The Spanish Cardiac Imaging Registry of 2022 allows us to know the current situation and temporal trend in terms of resources and activity, the differences between centers and identify potential areas of improvement for the future.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 43-52"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143171069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Utilidad del estudio genético en la fibrilación auricular de inicio precoz

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.08.001

Carlos Gómez Navarro , Beatriz Girela Pérez , José Gregorio Soto Rojas , Francisco José Bermúdez Jiménez , Antonio Bonilla López , Juan Jiménez-Jaimez

引用次数: 0

Perforación coronaria espontánea complicada con un hemotórax masivo

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.07.005

Adrián Costa Santos , Ane Elorriaga Madariaga , Abel Andrés Morist , Iván García Díaz

引用次数: 0

Hipertensión pulmonar por posible enfermedad relacionada con IgG4 可能与 IgG4 有关的疾病导致的肺动脉高压

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.05.001

Diana Isabel Katekaru-Tokeshi , Moisés Jiménez-Santos , Eric Kimura-Hayama

引用次数: 0

Indicación potencialmente alta de semaglutida en prevención secundaria en una región con alta prevalencia de obesidad 在肥胖症高发地区，semaglutide 在二级预防中的潜在高适应症

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.07.001

Francisco Buendía-Santiago, Antonio Meseguer-Hernández, José Manuel Andreu-Cayuelas, María del Carmen Guirao-Balsalobre, María del Rosario Mármol-Lozano, Juan Antonio Castillo-Moreno

引用次数: 0

Continuidad asistencial entre cardiología y AP en pacientes con cardiopatía isquémica crónica: diseño del estudio CAPRICI

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.07.004

Sergio Cinza-Sanjurjo , José Seijas-Amigo , Beatriz Fontela-Sánchez , Daniel Rey-Aldana , Paloma Sempere-Serrano , Pilar Mazón-Ramos , Diego Gabriel Mosteiro-Miguéns , Manuel Portela-Romero , Nerea Sánchez-Varela , Francisco Reyes-Santias , M. Teresa Ferreiro-Serrano , Mónica Barral-Carregal , Andrea Grela-Beiroa , Ana Suárez-Dios , Isabel Rego-Lijó , Jose Ramón González-Juanatey

Introduction and objectives

The management of cardiovascular risk factors (CVRF) should be conducted in Primary Care, which is particularly crucial for patients with prior cardiovascular disease. A semi-annual follow-up, aligned with the guidelines of clinical practice and coinciding with the administration of an injectable drug like inclisiran, could enhance healthcare efficiency. The CAPRICI study aims to analyze whether the implementation of a follow-up program, with semi-annual visits parallel to the administration of inclisiran in Primary Care, in patients with chronic ischemic heart disease, allows for optimized follow-up and improved control of CVRF.

Methods

The CAPRICI study is a randomized, controlled, prospective, multicenter trial involving 5 health centers in the Health Area of Santiago de Compostela and Barbanza: A Estrada, Concepción Arenal, Ribeira, Melide, and Milladoiro. The study will include patients with chronic coronary disease associated with other pathologies that increase cardiovascular risk, with elevated levels of low-density lipoprotein cholesterol (> 100 mg/dl) despite conventional treatment with high-potency statins, with or without ezetimibe. The number of visits to healthcare services, as well as the control of CVRF and lifestyle habits, will be recorded.

Conclusions

The results of this study will contribute to improving the knowledge about the care of patients at very high cardiovascular risk, particularly in optimizing the number of visits and hospital referrals, as well as in the control of their CVRF.

Clinicaltrials.gov identifier: NCT06421363

{"title":"Continuidad asistencial entre cardiología y AP en pacientes con cardiopatía isquémica crónica: diseño del estudio CAPRICI","authors":"Sergio Cinza-Sanjurjo , José Seijas-Amigo , Beatriz Fontela-Sánchez , Daniel Rey-Aldana , Paloma Sempere-Serrano , Pilar Mazón-Ramos , Diego Gabriel Mosteiro-Miguéns , Manuel Portela-Romero , Nerea Sánchez-Varela , Francisco Reyes-Santias , M. Teresa Ferreiro-Serrano , Mónica Barral-Carregal , Andrea Grela-Beiroa , Ana Suárez-Dios , Isabel Rego-Lijó , Jose Ramón González-Juanatey","doi":"10.1016/j.rccl.2024.07.004","DOIUrl":"10.1016/j.rccl.2024.07.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The management of cardiovascular risk factors (CVRF) should be conducted in Primary Care, which is particularly crucial for patients with prior cardiovascular disease. A semi-annual follow-up, aligned with the guidelines of clinical practice and coinciding with the administration of an injectable drug like inclisiran, could enhance healthcare efficiency. The CAPRICI study aims to analyze whether the implementation of a follow-up program, with semi-annual visits parallel to the administration of inclisiran in Primary Care, in patients with chronic ischemic heart disease, allows for optimized follow-up and improved control of CVRF.</div></div><div><h3>Methods</h3><div>The CAPRICI study is a randomized, controlled, prospective, multicenter trial involving 5 health centers in the Health Area of Santiago de Compostela and Barbanza: A Estrada, Concepción Arenal, Ribeira, Melide, and Milladoiro. The study will include patients with chronic coronary disease associated with other pathologies that increase cardiovascular risk, with elevated levels of low-density lipoprotein cholesterol (> 100 mg/dl) despite conventional treatment with high-potency statins, with or without ezetimibe. The number of visits to healthcare services, as well as the control of CVRF and lifestyle habits, will be recorded.</div></div><div><h3>Conclusions</h3><div>The results of this study will contribute to improving the knowledge about the care of patients at very high cardiovascular risk, particularly in optimizing the number of visits and hospital referrals, as well as in the control of their CVRF.</div><div>Clinicaltrials.gov identifier: <span><span>NCT06421363</span><svg><path></path></svg></span></div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 8-16"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hipotensión en pacientes con síncope: prueba de basculación y monitorización de la presión arterial en la práctica clínica

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.07.002

Graciela Aurora Ruiz, Silvia Makhoul, Miguel Agustini, Vanina N. Gos Re, Sofía Maza, Julia Zarate, Paola Tombesi, Simon Salzberg

Introduction and objectives

Both ambulatory blood pressure monitoring (ABPM) and tilt-test (TT) can identify the hypotensive component that predisposes to syncope. The aim was to establish the prevalence of hypotension in ABPM and TT and to establish the concordance of the results between both methods.

Methods

Patients ≥ 18 years with syncope in whom it was decided to perform a TT (45 min at 75̊) were included. An ABPM was performed on different dates. The criteria of hypotension were: in TT, TT (+) or detection of systolic blood pressure ≤ 100 mmHg during the study, resulting from a drop respect to baseline systolic blood pressure; in ABPM, ≥ 2 falls ≥ 20 mmHg with respect to the previous one reaching systolic blood pressure ≤ 100 mmHg.

Results

A total of 61 patients were studied (62.5 ± 16.8 years, 39 women [64%]). TT was positive in 41% of the patients. Additionally, during TT, hypotension was detected in another 18% of patients and hypotension by ABPM was observed in the 51%. Combining both methods, hypotension was detected in 79% of the population (48 patients). Both studies were concordant in 32 patients (52%) (Cohen kappa index: 0.04). Hypotension was identified in 28% of patients only by TT and in 20% only by ABPM.

Conclusions

Using a strategy combining TT and ABPM, hypotension was detected in three quarters of this population with syncope. Both methods proved to be complementary not only to develop a diagnostic suspicion but also to guide the therapeutic management of these patients.

{"title":"Hipotensión en pacientes con síncope: prueba de basculación y monitorización de la presión arterial en la práctica clínica","authors":"Graciela Aurora Ruiz, Silvia Makhoul, Miguel Agustini, Vanina N. Gos Re, Sofía Maza, Julia Zarate, Paola Tombesi, Simon Salzberg","doi":"10.1016/j.rccl.2024.07.002","DOIUrl":"10.1016/j.rccl.2024.07.002","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Both ambulatory blood pressure monitoring (ABPM) and tilt-test (TT) can identify the hypotensive component that predisposes to syncope. The aim was to establish the prevalence of hypotension in ABPM and TT and to establish the concordance of the results between both methods.</div></div><div><h3>Methods</h3><div>Patients≥18 years with syncope in whom it was decided to perform a TT (45min at 75̊) were included. An ABPM was performed on different dates. The criteria of hypotension were: in TT, TT (+) or detection of systolic blood pressure≤100mmHg during the study, resulting from a drop respect to baseline systolic blood pressure; in ABPM, ≥2 falls≥20mmHg with respect to the previous one reaching systolic blood pressure≤100mmHg.</div></div><div><h3>Results</h3><div>A total of 61 patients were studied (62.5±16.8 years, 39 women [64%]). TT was positive in 41% of the patients. Additionally, during TT, hypotension was detected in another 18% of patients and hypotension by ABPM was observed in the 51%. Combining both methods, hypotension was detected in 79% of the population (48 patients). Both studies were concordant in 32 patients (52%) (Cohen kappa index: 0.04). Hypotension was identified in 28% of patients only by TT and in 20% only by ABPM.</div></div><div><h3>Conclusions</h3><div>Using a strategy combining TT and ABPM, hypotension was detected in three quarters of this population with syncope. Both methods proved to be complementary not only to develop a diagnostic suspicion but also to guide the therapeutic management of these patients.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 26-33"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Improving quality of life through a cardiac rehabilitation program: a 4-wave longitudinal study

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.07.008

M. José Ferreira-Díaz , Ana Laguía , Gabriela Topa

Introduction and objectives

Given the importance of cardiovascular disease, the leading cause of death in the world, and the fact that in Spain only 2–3% of the population can benefit from access to cardiac rehabilitation programs, the aim of this study is to consider the measurement of quality of life as a good indicator to determine the effectiveness of these programs. This longitudinal study evaluates the impact of a cardiac rehabilitation program on quality of life in a cohort of 181 patients at a Spanish hospital for 2 years.

Methods

Quality of life was assessed at four time points: on admission to the program, at discharge after 12 weeks, and at the 4- and 12-month revisions.

Results

The results show an increase in the perception of quality of life compared to the initial situation of the patients at the time of admission to the rehabilitation program, with positive results being observed in practically all the domains of the questionnaire, obtaining a higher score in the physical role domain.

Conclusions

This study shows that attendance at a cardiac rehabilitation program significantly improves self-perception of health, both physical and emotional.

{"title":"Improving quality of life through a cardiac rehabilitation program: a 4-wave longitudinal study","authors":"M. José Ferreira-Díaz , Ana Laguía , Gabriela Topa","doi":"10.1016/j.rccl.2024.07.008","DOIUrl":"10.1016/j.rccl.2024.07.008","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Given the importance of cardiovascular disease, the leading cause of death in the world, and the fact that in Spain only 2–3% of the population can benefit from access to cardiac rehabilitation programs, the aim of this study is to consider the measurement of quality of life as a good indicator to determine the effectiveness of these programs. This longitudinal study evaluates the impact of a cardiac rehabilitation program on quality of life in a cohort of 181 patients at a Spanish hospital for 2 years.</div></div><div><h3>Methods</h3><div>Quality of life was assessed at four time points: on admission to the program, at discharge after 12 weeks, and at the 4- and 12-month revisions.</div></div><div><h3>Results</h3><div>The results show an increase in the perception of quality of life compared to the initial situation of the patients at the time of admission to the rehabilitation program, with positive results being observed in practically all the domains of the questionnaire, obtaining a higher score in the physical role domain.</div></div><div><h3>Conclusions</h3><div>This study shows that attendance at a cardiac rehabilitation program significantly improves self-perception of health, both physical and emotional.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 34-42"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143171071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Frecuencia y distribución geográfica de la prescripción de inhibidores de PCSK9 en Colombia entre 2019 y 2021 2019年至2021年哥伦比亚PCSK9抑制剂处方的频率和地理分布

Q4 Medicine

REC: CardioClinics

Pub Date : 2025-01-01 DOI: 10.1016/j.rccl.2024.06.003

Tatiana Ramírez-Peña , David Corredor-Orlandelli , Daniel G. Fernández-Ávila , Ángel Alberto García , Óscar Muñoz-Velandia

Introduction and objectives

Proprotein convertase subtilisin/kexin type 9 convertase inhibitors (iPCSK9) effectively reduce low-density lipoprotein cholesterol and have been shown to decrease cardiovascular morbidity and mortality in high-risk patients. However, their cost hinders their real accessibility. This study seeks to describe variables related to iPCSK9 prescription in Colombia.

Methods

Population-based analysis of iPCSK9 prescriptions in Colombia during the years 2019-2021, based on data from the government database Sistema Integrado de Información de la Protección Social. Information was extracted on sex, age groups, geographical area (department), health regime, ICD-10 code and the professional profile of the prescriber.

Results

There were 7431 prescriptions, 49.5% for alirocumab and 50.5% for evolocumab. Most patients were men > 50 years old. The contributory regimen formulation was higher with a prescription rate ratio of 6.59 (95%CI, 6.147-7.073, P < .01). The most populated areas had the highest prescribing, while six departments had no prescriptions. The most common indications were dyslipidaemia and ischaemic heart disease, with cardiologists and internists being the main prescribers.

Conclusions

Formulation of iPCSK9 was lower than expected. There were more formulations in men and people > 50 years, data compatible with the higher incidence of cardiovascular disease in this population group. Regions with higher population density had more formulations and some areas, mainly rural, have no penetration. The marked differences in access between regions and regimens require further analysis to identify possible barriers to access.

{"title":"Frecuencia y distribución geográfica de la prescripción de inhibidores de PCSK9 en Colombia entre 2019 y 2021","authors":"Tatiana Ramírez-Peña , David Corredor-Orlandelli , Daniel G. Fernández-Ávila , Ángel Alberto García , Óscar Muñoz-Velandia","doi":"10.1016/j.rccl.2024.06.003","DOIUrl":"10.1016/j.rccl.2024.06.003","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Proprotein convertase subtilisin/kexin type9 convertase inhibitors (iPCSK9) effectively reduce low-density lipoprotein cholesterol and have been shown to decrease cardiovascular morbidity and mortality in high-risk patients. However, their cost hinders their real accessibility. This study seeks to describe variables related to iPCSK9 prescription in Colombia.</div></div><div><h3>Methods</h3><div>Population-based analysis of iPCSK9 prescriptions in Colombia during the years 2019-2021, based on data from the government database <em>Sistema Integrado de Información de la Protección Social</em>. Information was extracted on sex, age groups, geographical area (department), health regime, ICD-10 code and the professional profile of the prescriber.</div></div><div><h3>Results</h3><div>There were 7431 prescriptions, 49.5% for alirocumab and 50.5% for evolocumab. Most patients were men >50years old. The contributory regimen formulation was higher with a prescription rate ratio of 6.59 (95%CI, 6.147-7.073, <em>P</em>    <!-->years, data compatible with the higher incidence of cardiovascular disease in this population group. Regions with higher population density had more formulations and some areas, mainly rural, have no penetration. The marked differences in access between regions and regimens require further analysis to identify possible barriers to access.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 17-25"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141843591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

REC: CardioClinics

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀